234 related articles for article (PubMed ID: 30200981)
1. Comprehensive off-target analysis of dCas9-SAM-mediated HIV reactivation via long noncoding RNA and mRNA profiling.
Zhang Y; Arango G; Li F; Xiao X; Putatunda R; Yu J; Yang XF; Wang H; Watson LT; Zhang L; Hu W
BMC Med Genomics; 2018 Sep; 11(1):78. PubMed ID: 30200981
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/gRNA-directed synergistic activation mediator (SAM) induces specific, persistent and robust reactivation of the HIV-1 latent reservoirs.
Zhang Y; Yin C; Zhang T; Li F; Yang W; Kaminski R; Fagan PR; Putatunda R; Young WB; Khalili K; Hu W
Sci Rep; 2015 Nov; 5():16277. PubMed ID: 26538064
[TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA uc002yug.2 Activates HIV-1 Latency through Regulation of mRNA Levels of Various RUNX1 Isoforms and Increased Tat Expression.
Huan C; Li Z; Ning S; Wang H; Yu XF; Zhang W
J Virol; 2018 May; 92(9):. PubMed ID: 29491162
[TBL] [Abstract][Full Text] [Related]
4. Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator Complex.
Saayman SM; Lazar DC; Scott TA; Hart JR; Takahashi M; Burnett JC; Planelles V; Morris KV; Weinberg MS
Mol Ther; 2016 Mar; 24(3):488-98. PubMed ID: 26581162
[TBL] [Abstract][Full Text] [Related]
5. Specific Reactivation of Latent HIV-1 by dCas9-SunTag-VP64-mediated Guide RNA Targeting the HIV-1 Promoter.
Ji H; Jiang Z; Lu P; Ma L; Li C; Pan H; Fu Z; Qu X; Wang P; Deng J; Yang X; Wang J; Zhu H
Mol Ther; 2016 Mar; 24(3):508-21. PubMed ID: 26775808
[TBL] [Abstract][Full Text] [Related]
6. Targeted Chromatinization and Repression of HIV-1 Provirus Transcription with Repurposed CRISPR/Cas9.
Olson A; Basukala B; Lee S; Gagne M; Wong WW; Henderson AJ
Viruses; 2020 Oct; 12(10):. PubMed ID: 33053801
[TBL] [Abstract][Full Text] [Related]
7. Repression of HIV-1 reactivation mediated by CRISPR/dCas9-KRAB in lymphoid and myeloid cell models.
da Costa LC; Bomfim LM; Dittz UVT; Velozo CA; da Cunha RD; Tanuri A
Retrovirology; 2022 Jun; 19(1):12. PubMed ID: 35733180
[TBL] [Abstract][Full Text] [Related]
8. NF-κB-Interacting Long Noncoding RNA Regulates HIV-1 Replication and Latency by Repressing NF-κB Signaling.
Wang H; Liu Y; Huan C; Yang J; Li Z; Zheng B; Wang Y; Zhang W
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581100
[TBL] [Abstract][Full Text] [Related]
9. Viral diversity is an obligate consideration in CRISPR/Cas9 designs for targeting the HIV reservoir.
Roychoudhury P; De Silva Feelixge H; Reeves D; Mayer BT; Stone D; Schiffer JT; Jerome KR
BMC Biol; 2018 Jul; 16(1):75. PubMed ID: 29996827
[TBL] [Abstract][Full Text] [Related]
10. Functional properties of the HIV-1 long terminal repeat containing single-nucleotide polymorphisms in Sp site III and CCAAT/enhancer binding protein site I.
Shah S; Alexaki A; Pirrone V; Dahiya S; Nonnemacher MR; Wigdahl B
Virol J; 2014 May; 11():92. PubMed ID: 24886416
[TBL] [Abstract][Full Text] [Related]
11. Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus.
Ebina H; Misawa N; Kanemura Y; Koyanagi Y
Sci Rep; 2013; 3():2510. PubMed ID: 23974631
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA MALAT1 releases epigenetic silencing of HIV-1 replication by displacing the polycomb repressive complex 2 from binding to the LTR promoter.
Qu D; Sun WW; Li L; Ma L; Sun L; Jin X; Li T; Hou W; Wang JH
Nucleic Acids Res; 2019 Apr; 47(6):3013-3027. PubMed ID: 30788509
[TBL] [Abstract][Full Text] [Related]
13. RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection.
Hu W; Kaminski R; Yang F; Zhang Y; Cosentino L; Li F; Luo B; Alvarez-Carbonell D; Garcia-Mesa Y; Karn J; Mo X; Khalili K
Proc Natl Acad Sci U S A; 2014 Aug; 111(31):11461-6. PubMed ID: 25049410
[TBL] [Abstract][Full Text] [Related]
14. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
15. Long-term suppression of HIV-1C virus production in human peripheral blood mononuclear cells by LTR heterochromatization with a short double-stranded RNA.
Singh A; Palanichamy JK; Ramalingam P; Kassab MA; Bhagat M; Andrabi R; Luthra K; Sinha S; Chattopadhyay P
J Antimicrob Chemother; 2014 Feb; 69(2):404-15. PubMed ID: 24022068
[TBL] [Abstract][Full Text] [Related]
16. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
[TBL] [Abstract][Full Text] [Related]
17. Repressive LTR nucleosome positioning by the BAF complex is required for HIV latency.
Rafati H; Parra M; Hakre S; Moshkin Y; Verdin E; Mahmoudi T
PLoS Biol; 2011 Nov; 9(11):e1001206. PubMed ID: 22140357
[TBL] [Abstract][Full Text] [Related]
18. Systematic HIV-1 promoter targeting with CRISPR/dCas9-VPR reveals optimal region for activation of the latent provirus.
Klinnert S; Chemnitzer A; Rusert P; Metzner KJ
J Gen Virol; 2022 Jun; 103(6):. PubMed ID: 35671066
[TBL] [Abstract][Full Text] [Related]
19. Gesicle-Mediated Delivery of CRISPR/Cas9 Ribonucleoprotein Complex for Inactivating the HIV Provirus.
Campbell LA; Coke LM; Richie CT; Fortuno LV; Park AY; Harvey BK
Mol Ther; 2019 Jan; 27(1):151-163. PubMed ID: 30389355
[TBL] [Abstract][Full Text] [Related]
20. RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency.
Méndez C; Ledger S; Petoumenos K; Ahlenstiel C; Kelleher AD
Retrovirology; 2018 Oct; 15(1):67. PubMed ID: 30286764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
